If you're wondering whether a GLP-1 medication might be appropriate for your situation, it's worth a conversation with a provider who understands the complexity of EDS and its associated conditions
There is currently no robust clinical evidence supporting GLP-1 use in rheumatoid arthritis
Victoza is typically less expensive ($800-900/month vs $1,300-1,400/month for Saxenda) and has better insurance coverage for diabetes patients
How PlexusDx Supports a More Personalized Approach While PlexusDx specializes in compounded peptide therapeutics rather than standalone antioxidant supplementation, understanding genetic predispositions in metabolic and mitochondrial pathways may help provide context for how individual patients respond to oxidative stress interventions
Independent Pharmacy and Specialty Pharmacy Operators For private equity and strategic investors in independent pharmacy or specialty pharmacy, the regulatory environment in 2025-2026 is more favorable than at any point in the past 15 years, given the momentum behind structural PBM reform
The information on this website is intended to support understanding, not to provide medical diagnosis, treatment, or individualized health advice